Takeda geeft presentatie op 34e J.P. Morgan Healthcare Conference
OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited heeft vandaag bekendgemaakt dat Christophe Weber, president en ceo van Takeda, geeft op 12 januari een officiële presentatie op de J.P. Morgan Healthcare Conference in San Francisco. Na afloop is er tijd voor een vraag- en antwoordsessie.
|
Details over het tijdstip en toegang tot de audio-webcast, zijn als volgt: |
|||
|
Datum en tijd |
Dinsdag 12 januari 11:30am – 12:30pm (Pacific Standard Time)
[Woensdag 13 januari 4:30am – 5:30am (Japan Standard Time)] |
||
|
Agenda |
● |
Presentatie (25 minuten): Takeda Strategic Update |
|
|
(Noot: Inclusief updates over verkoopcijfers ENTYVIO ® in oktober en decemebr 2015, en Takeda’s onderzoek en ontwikkeling) |
|||
|
● |
Vraag- en antwoordsessie (25 minuten) Christophe Weber, president en ceo Andrew Plump, hoofd onderzoek en wetenschap Rudolf van Houten, opererend financieel directeur Christophe Bianchi, voorzitter Global Oncology Business Unit |
||
|
Toegang tot audiowebcast |
|||
|
● |
Inschrijving vooraf is vereist. Bezoek de bovenstaande URL enkele minuten voor de presentatie. |
||
|
● |
Naast de live webcast is de audio 90 dagen na de presentatie op aanvraag beschikbaar. |
||
|
Presentatie- |
Takeda uploadt presentatiematerialen op het moment van het begin van de presentatie: |
||
|
Noot: Audio en materialen zijn uitsluitend in Engels. |
|||
Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TOKYO: 4502) (“Takeda”) today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, at the 34th Annual J.P. Morgan Healthcare Conference held in San Francisco, California. The presentation will be followed by a Q&A session.
|
Details of the timing, and how to access the audio webcast and presentation materials, are as follows. |
|||
|
Date and |
Tuesday January 12, at 11:30am – 12:30pm (Pacific Standard Time)
[Wednesday January 13, at 4:30am – 5:30am (Japan Standard Time)] |
||
|
Agenda |
● |
Presentation (25 minutes): Takeda Strategic Update |
|
|
(Note: Includes updates on ENTYVIO ® sales from Oct-Dec 2015, and Takeda’s direction in R&D) |
|||
|
● |
Q&A session (25 minutes) Christophe Weber, President and Chief Executive Officer Andrew Plump, Chief Medical & Scientific Officer Rudolf van Houten, acting Chief Financial Officer Christophe Bianchi, President, Global Oncology Business Unit |
||
|
Access to |
|||
|
● |
Registration is required in advance, so please visit the URL a few minutes before the presentation is scheduled to begin. |
||
|
● |
In addition to a live webcast, the audio will also be available on-demand at this URL for 90 days following the event. |
||
|
Access to |
Presentation materials will be uploaded to Takeda’s website at the same time as the presentation begins: |
||
|
Note: Audio and materials are available only in English. |
|||
About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda (TOKYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160107006438/en/
Contacts
Media Contacts:
Takeda Pharmaceutical Company Limited
Tsuyoshi Tada, +81 3-3278-2417
tsuyoshi.tada@takeda.com
Inves tor Contacts:
Takeda Pharmaceutical Company Limited
Noriko Higuchi, +81 3-3278-2306
noriko.higuchi@takeda.com